ABBOTT LABORATORIES — Director's Dealing 2014

Feb 25, 2014

Page 1 of 1

SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB Number: 3235-0287 December 31, Expires: 2014 Estimated average burden hours per 0.5 response:

1. Name and Address of Reporting Person* DeVos Georges H.	1. Name and Address of Reporting Person* DeVos Georges H.	1. Name and Address of Reporting Person* DeVos Georges H.	1. Name and Address of Reporting Person* DeVos Georges H.		2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT	2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT	]		5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner
(Last) 100 ABBOTT	(First) (Middle) PARK ROAD				3. Date of Earliest Transaction (Month/Day/Year) 02/21/2014							X	Officer (give title below) Other (specify below) Senior Vice President
					4.	If Amendment, Date of		Original Filed	(Month/Day/Year)			6. Individual or Joint/Group Filing (Check Applicable
(Street)												Line)
ABBOTT PARK		IL	60064-6092									X	Form filed Form filed	by One Reporting Person by More than One Reporting
													Person
(City)		(State)	(Zip)
			Table I -	Non-Derivative Securities Acquired, Disposed						of,	or Beneficially Owned
1. Title of Security (Instr. 3)					2. Transaction Date		2A. Deemed Execution Date, 3. Transaction			4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and			5. Amount Securities	of	6. Ownership Form: Direct		7. Nature of Indirect
					(Month/Day/Year) if any			Code	(Instr.	5)			Beneficially		(D) or Indirect		Beneficial
							(Month/Day/Year) 8)						Owned Following		(I) (Instr. 4)		Ownership
													Reported				(Instr. 4)
								Code	V	Amount (A) (D)		or Price	Transaction(s) (Instr. 3 and 4)
			Table	II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
				(e.g., puts,		calls, warrants, options, convertible					securities)
1. Title of	2.		3. Transaction	3A. Deemed	4.		5. Number of	6. Date Exercisable and			7. Title and Amount of		8. Price of	9. Number		10.	11. Nature
Derivative Security	Conversion		Date	Execution Date,	Transaction		Derivative	Expiration Date			Securities Underlying		Derivative	of		Ownership	of Indirect
(Instr. 3)	or	Exercise	(Month/Day/Year)	if any	Code (Instr.		Securities	(Month/Day/Year)			Derivative Security		Security	derivative		Form:	Beneficial
	Price of			(Month/Day/Year)	8)		Acquired (A)				(Instr. 3 and	4)	(Instr. 5)	Securities		Direct (D)	Ownership
	Derivative						or Disposed							Beneficially		or Indirect	(Instr. 4)
	Security						of (D) (Instr.							Owned		(I) (Instr. 4)
							3, 4 and 5)							Following
														Reported
												Amount		Transaction
												or		(s) (Instr. 4)
												Number
								Date	Expiration			of
					Code V		(A) (D)	Exercisable	Date		Title	Shares
Option (right to buy) (1)		$39.12	02/21/2014			A	81,940	02/21/2015	02/20/2024		Common shares	81,940	$0	81,940		D

Explanation of Responses:

1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,314 on 2/21/2015, 27,313 on 2/21/2016, and 27,313 on 2/21/2017.

John A. Berry, by power of 02/25/2014 attorney for Georges H. DeVos ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/25/2014